menu search

Plx pharma inc. enters into a stalking horse asset purchase agreement to sell vazalore® and substantially all of its assets

SPARTA, N.J., April 12, 2023 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a commercial-stage drug delivery...

April 12, 2023, 9:24 pm

Plx pharma inc. to discuss 2022 first quarter financial results on may 13, 2022 conference call and provide business update

SPARTA, N.J., April 22, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery ...

April 22, 2022, 6:50 am

Plx pharma inc. to present at oppenheimer & co's 32nd annual healthcare conference on march 15, 2022

SPARTA, N.J., March 01, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery ...

March 1, 2022, 6:50 am

Plx pharma inc. to present at oppenheimer & co's 32nd annual healthcare conference on march 15, 2022

SPARTA, N.J., March 01, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery ...

March 1, 2022, 6:50 am

Plx pharma inc. to present at oppenheimer & co's 32nd annual healthcare conference on march 15, 2022

SPARTA, N.J., March 01, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery ...

March 1, 2022, 6:50 am


Search within

Pages Search Results: